A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition:   Autosomal Dominant Polycystic Kidney Disease Interventions:   Drug: GLPG2737;   Drug: Placebo Sponsor:   Galapagos NV Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2020 Category: Research Source Type: clinical trials